CClinicalTrials.gg
CompletedNCT03670394Updated Apr 17, 2020

Capillary Refill for Assessment of Dehydration

An observational study in Dehydration in Children, sponsored by Oregon Health and Science University. Completed at 1 site in United States. Open to participants aged 6 Months to 10 Years. Per ClinicalTrials.gov, last updated 2020-04-17.

Sponsored by Oregon Health and Science University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
178
Ages
6 Months to 10 Years
Sex
All
01

Study summary

Capillary refill is used clinically to assess multiple things in children. This is a prospective observational study of the correlation between capillary refill time and degree of dehydration in children seen in a pediatric ED.

Read the detailed description

All patient presenting to the pediatric ER at OHSU less than 10 years are eligible to be enrolled if being seen for a condition putting them at risk for dehydration including emesis, diarrhea, etc. Children will have their capillary refill time measured and then sent home with a digital scale to track their weight. This will serve as the standard for calculating percent dehydration. When a patient has reached a stable weight at 1 week we will assume this is their healthy weight. There is no intervention in the study.

02

Conditions studied

  • Dehydration in Children

Browse trials for

03

In context

Dehydration

204 studies on the registry are indexed under Dehydration; 29 are open to participants now.

This study's enrollment of 178 is above the median of 101 across 48 observational studies indexed under Dehydration.

Browse Dehydration studies →

Lead sponsor

Oregon Health and Science University is the lead sponsor of 676 studies on the registry; 136 are open to participants now.

Of its 49 completed or terminated interventional studies of FDA-regulated products, 36 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Months to 10 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

All patients presenting to the pediatric ER at OHSu.

Inclusion criteria

  • All children with chief complaint of diarrhea, emesis, nausea, abdominal pain

Exclusion criteria

Exclusion Criteria:

  • Any child with chronic cardiac or pulm disease, raynauds syndrome, bilateral upper extremity trauma, previously enrolled in the study, already received IVF in the previous 48hrs, surgery within 1week, osteogenesis imperfecta.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
178 participants (actual)
Patient registry
No

Interventions

  • Diagnostic testCapillary Refill

    We are measuring capillary refill to assess it's correlation with dehydration in children

06

What researchers measure

Primary outcomes

  1. Capillary Refill time

    Assessing correlation of the refill time and percent dehydration

    Time frame: 1 week

07

Study locations

1 site
  • OHSU
    Portland, Oregon 97239, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 17, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03670394
Lead sponsor
Oregon Health and Science University
Responsible party
Dr. David Sheridan (Assistant professor, Oregon Health and Science University) — Principal investigator
First posted
Sep 13, 2018
Start date
Sep 10, 2018
Primary completion
Apr 1, 2020
Completion
Apr 1, 2020
Last update
Apr 17, 2020

Study contacts

David Sheridan, MD MR
principal investigator · Oregon Health and Science University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion